Results 161 to 170 of about 42,452 (228)

Secondary hyperparathyroidism: what we know and what we are still learning. [PDF]

J Bras Nefrol
Litchteneker K, Bucharles SGE, Barreto FC.   +2 more
europepmc   +1 more source

Assessment of quality of life following subtotal parathyroidectomy in patients with secondary hyperparathyroidism resulting from end-stage renal disease: a single-center prospective study in Vietnam. [PDF]

BMC Nephrol
Hiep PH, Luong TN, Hung DQ, Ket TD, Ngoc NA, Truong VM, Duc PT, Huy TQ, Ho ND, Anh DT, Quyen DVT, Hung BV, Hung DT.   +12 more
europepmc   +1 more source

Pharmacodynamic Modeling of Cinacalcet in Secondary Hyperparathyroidism: Efficacy and Influencing Factors Analysis. [PDF]

J Endocr Soc
Wang Z, Wang Y, Han S, Chen P, Wu R, Fang C, Cheng J, Wu Y, Guo T, Wen X, Li L.   +10 more
europepmc   +1 more source

Vitamin D: an important treatment for secondary hyperparathyroidism in chronic kidney disease? [PDF]

Int Urol Nephrol
Yu J, Li Y, Zhu B, Shen J, Miao L.
europepmc   +1 more source

Pathogenesis of Secondary Hyperparathyroidism

Kidney and Blood Pressure Research, 1997
openaire   +2 more sources

Predictors of Hungry Bone Syndrome After Parathyroidectomy in Secondary Hyperparathyroidism: A Narrative Review of Bone Turnover Biomarkers and Risk Prediction Tools. [PDF]

J Clin Med
Coman A, Tarta C, Isaic A, Marian M, Olariu S, Ardelean A, Macovei-Oprescu AM, Roland F, Pupca GN, Latcu S, Suciu CS, Murariu M.   +11 more
europepmc   +1 more source

From Secondary Hyperparathyroidism to Neurologic Crisis: A Tale of Brown Tumor and Spinal Cord Compression. [PDF]

JCEM Case Rep
Kormanis A, Anderson M, McKnight M, Darapu H.   +3 more
europepmc   +1 more source

Real-world safety profile of etelcalcetide in dialysis-related secondary hyperparathyroidism: a pharmacovigilance analysis of FAERS data. [PDF]

Ren Fail
Zou C, Wang X, Huang R, Hu H.
europepmc   +1 more source

Severe Symptomatic Hypocalcemia after Denosumab Administration in an End-Stage Renal Disease Patient on Peritoneal Dialysis with Controlled Secondary Hyperparathyroidism [PDF]

, 2019
Agarwal, Mohit, Csongrádi, Éva, Echols, Vonda, Fülöp, Tibor, Juncos, Luis A., Koch, Christian A., Tapolyai, Mihály   +6 more
core  

Stattic engineering M2 macrophage-derived exosomes mediate autophagy and immune reprogramming for secondary hyperparathyroidism. [PDF]

J Adv Res
Li P, Liao R, Li J, Chen S, Diao W, Shi K, Zuo C, Tan S, Li J, Jiang Z, Hu Y, Wu W, Zhou J.   +12 more
europepmc   +1 more source